Project 23-01 autoinjector - kaleo

Other Transaction IDV Awarded Last action

Contract number
W911SR2390013
Awardee
Awarding agency
Task orders
0

Award facts

Last date to order
Not on record
IDV ceiling
$39,772,161.00
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
NAICS code
Not on record
Set-aside
No set-aside
Competition
Competed Broad Agency Announcement
Pricing
Other

Award details come from SAM.gov/FPDS.

About this IDV

Kaleo, Inc. was awarded a $39.77 million Other Transaction Indefinite Delivery Vehicle (IDV) by the Joint Program Executive Office for Chemical and Biological Defense under the Department of the Army on July 31, 2023. This multiple-award IDV, designated Project 23-01 Autoinjector, supports the development and procurement of autoinjector devices and associated services for medical countermeasures within the chemical and biological defense portfolio. The contract does not utilize a small business set-aside. As the prime contractor, Kaleo will leverage its established expertise in autoinjector design and manufacturing to fulfill government requirements under this vehicle.

The fundamental purpose of this IDV is to develop an autoinjector capable of reconstituting a range of medical countermeasures, with initial development and commercialization efforts focused on an atropine autoinjector leading to New Drug Application approval. This aligns with the Defense Department's broader chemical and biological defense mission requirements and Kaleo's existing role as a critical supplier of lifesaving autoinjector devices to federal agencies. The IDV structure enables efficient procurement of autoinjector devices and related services across multiple task orders, supporting both prototype development activities and potential supply needs for strategic medical countermeasures inventories. No specific places of performance, period of performance details, or individual task order information was provided in the available materials.

Transactions

Action Obligated Date
Funding Only Action P00008 $242,233
Funding Only Action P00007 $3,235,999
Funding Only Action P00006 $3,084,001
Other Administrative Action P00005 $0
Funding Only Action P00004 $7,575,726
Other Administrative Action P00003 · The purpose of this agreement is to develop an autoinjector capable of reconstituting a range of medical countermeasures. $0
Funding Only Action P00002 · To develop an autoinjector capable of reconstituting a range of medical countermeasures demonstrated through the initial prototype development. $3,213,443
Other Administrative Action P00001 $0
Original award $6,052,109

Quick answers

Who was awarded contract W911SR2390013?

W911SR2390013 was awarded to Kaleo, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on July 31, 2023.

How much is contract W911SR2390013 worth?

W911SR2390013's own ceiling is $39,772,161.

Which agency awarded contract W911SR2390013?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR2390013, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911SR2390013 competed?

The extent of competition for W911SR2390013 was competed.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV